- Home
- BSM vs CNTA Comparison
BSM vs CNTA Comparison
Compare BSM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSM | CNTA |
|---|---|---|
| Founded | 1876 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSM | CNTA |
|---|---|---|
| Price | $14.99 | $23.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $13.00 | ★ $38.50 |
| AVG Volume (30 Days) | 344.4K | ★ 1.6M |
| Earning Date | 02-23-2026 | 03-23-2026 |
| Dividend Yield | ★ 8.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | ★ $412,814,000.00 | $15,000,000.00 |
| Revenue This Year | $1.58 | N/A |
| Revenue Next Year | $8.38 | N/A |
| P/E Ratio | $12.96 | ★ N/A |
| Revenue Growth | N/A | ★ 118.88 |
| 52 Week Low | $11.78 | $9.60 |
| 52 Week High | $15.52 | $30.58 |
Technical Indicators
Market Signals| Indicator | BSM | CNTA |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 43.38 |
| Support Level | $14.65 | $23.41 |
| Resistance Level | $14.99 | $26.51 |
| Average True Range (ATR) | 0.28 | 1.42 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 71.27 | 40.16 |
Price Performance
Historical ComparisonAbout BSM Black Stone Minerals L.P.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.